|
Release date as of 2024-10-31. Data on page is subject to change. |
|
|
Style Box Details for Stock Holdings |
|
Size |
|
Average Mkt Cap $Mil |
87,115 |
|
|
Market Capitalization |
% of Portfolio |
Giant |
24.12 |
Large |
45.77 |
Medium |
15.90 |
Small |
11.29 |
Micro |
2.92 |
|
|
|
Investment Valuation |
Stock Portfolio
|
Forward P/E |
22.8 |
Price/Book |
5.5 |
Price/Sales |
2.4 |
Price/Cash Flow |
19.8 |
Dividend Yield |
0.7 |
Long-Term Earnings |
23.5 |
Historical Earnings |
2.6 |
Sales Growth |
10.3 |
Cash-Flow Growth |
9.8 |
Book-Value Growth |
10.0 |
|
|
|
|
|
As of 2024-09-30 |
|
|
|
% of Net Assets |
|
U.S. Stocks |
90.0 |
|
Non-U.S. Stocks |
7.9 |
|
Bonds |
0.0 |
|
Cash |
2.1 |
|
Other |
0.0 |
|
|
|
Data through 2024-09-30 |
|
|
|
Morningstar Equity Sectors |
|
|
|
% of Stocks |
|
Cyclical |
1.29 |
|
Basic Materials |
0.00 |
|
Consumer Cyclical |
0.00 |
|
Financial Services |
0.00 |
|
Real Estate |
1.29 |
|
|
|
|
Sensitive |
0.00 |
|
Communication Services |
0.00 |
|
Energy |
0.00 |
|
Industrials |
0.00 |
|
Technology |
0.00 |
|
|
|
|
Defensive |
98.71 |
|
Consumer Defensive |
0.00 |
|
Healthcare |
98.71 |
|
Utilities |
0.00 |
|
Data through 2024-09-30 |
|
|
|
Total Number of Stock Holdings |
81 |
Total Number of Bond Holdings |
0 |
% of Net Assets in Top 10 Holdings |
48.16 |
|
|
Turnover % |
(as of 2023-12-31) |
57.00 |
30 Day SEC Yield % |
--- |
|
|
Sector |
P/E |
% of Net Assets
|
|
|
|
|
|
|
Eli Lilly and Co |
|
89.41 |
9.39 |
|
Boston Scientific Corp |
|
69.44 |
6.60 |
|
UnitedHealth Group Inc |
|
36.70 |
5.38 |
|
Intuitive Surgical Inc |
|
81.00 |
4.35 |
|
Danaher Corp |
|
46.35 |
4.32 |
|
|
Thermo Fisher Scientific Inc |
|
34.25 |
3.79 |
|
Vertex Pharmaceuticals Inc |
|
--- |
3.77 |
|
AstraZeneca PLC ADR |
|
--- |
3.63 |
|
Regeneron Pharmaceuticals Inc |
|
20.73 |
3.50 |
|
Elevance Health Inc |
|
14.77 |
3.43 |
|
|
AbbVie Inc |
|
71.03 |
3.39 |
|
HCA Healthcare Inc |
|
16.11 |
3.09 |
|
Amgen Inc |
|
40.89 |
2.60 |
|
Tenet Healthcare Corp |
|
4.91 |
2.35 |
|
Zoetis Inc Class A |
|
35.05 |
2.09 |
|
|
Merck & Co Inc |
|
21.41 |
2.07 |
|
Stryker Corp |
|
38.19 |
1.95 |
|
Icon PLC |
|
24.71 |
1.61 |
|
Novo Nordisk AS Class B |
|
--- |
1.57 |
|
Encompass Health Corp |
|
23.40 |
1.55 |
|
|
Cencora Inc |
|
24.74 |
1.54 |
|
Invesco Shrt-Trm Inv Treasury Instl |
--- |
--- |
1.27 |
|
Natera Inc |
|
--- |
1.20 |
|
Alnylam Pharmaceuticals Inc |
|
--- |
1.09 |
|
Welltower Inc |
|
--- |
1.09 |
|
|
|
|
|
© Copyright 2024 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo, Morningstar.com, Morningstar Tools are either trademark or service marks of Morningstar, Inc. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or any losses arising from any use of information. Past performance is no guarantee of future performance. |
|
Past performance is no guarantee of future results.
Returns will vary and shares may be worth more or less than their original cost when sold.
|
|